Hsa_circ_0091579 |
Up |
|
Human |
- |
(Zhang, C. et al., 2018) |
Hsa_circ-101368 |
Up |
HMGB1/RAGE signaling |
Human, In vitro |
HCCLM3 |
(Li, S. et al., 2018) |
CircSETD3 (hsa_circRNA_0000567/hsa_circRNA_101436) |
Down |
|
Human, In vitro
|
|
(WHO, 2019) |
Hsa_circRNA-104718 |
Up |
miR-218–5p/TXNDC5 signaling pathway |
Human, In vivo
|
SMMC-7721, HepG2, MHCC-LM3, and SK-Hep1, HEK293T |
(Yu et al., 2019) |
Hsa_circ_0003570 |
Down |
alpha-fetoprotein |
Human, In vitro
|
HepG2, SMMC-7721, MHCC97L, MHCC97H, and HCCLM3, L02 |
(Fu et al., 2018) |
Hsa_circ_0068669 |
Down |
|
Human, In vitro
|
HCC |
(Yao et al., 2018) |
Hsa_circ_0078602 |
Down |
|
Human |
|
(Kou et al., 2019) |
Circ5379–6 |
Down |
|
In vitro, In vivo |
hepG2, 293T, Huh-7, SK-hep-1 |
(Zhang, N. et al., 2018) |
CSMARCA5 (hsa_circ_0001445) |
Down |
TIMP3, Sponging miR-17–3p and miR-181b-5p |
Human, In vitro, In vivo
|
|
(Yu, J. et al., 2018) |
CircPTGR1 |
Up |
miR449a-MET pathway |
In vitro |
HepG2, L-O2, SMCC-7721, HEP3B, HUH7, MHCC97-L (97 L), MHCC 97H (97H), HCC-LM3 (LM3) |
(Wang, G. et al., 2019) |
Hsa_circ_0079929 |
Down |
PI3K/AKT/mTOR signaling pathway |
Human, In vitro, In vivo
|
SK-Hep-1, SMMC-7721, 7702, LM-3, PRL-RF5 |
(Zheng et al., 2019) |
CircHIPK3 |
Up |
miR-124, AQP3 |
Human, In vitro
|
Huh7, MHCC-LM3, HepG2, SMMC-7721, PLC, L02, HEK293T |
(Chen, G. et al., 2018) |
Hsa_circ_0070269 |
Up |
miR-182/NPTX1 axis |
Human, In vitro
|
(Hep-3B, SMMC-7721, HepG2, PLC, Huh-7, LO2 |
(Su et al., 2019) |
Hsa_circ_0028502, hsa_circ_0076251 |
Down |
|
Human |
- |
(Jiang, Z. et al., 2019) |
circular RNA PVT1 |
Up |
miR-203/HOXD3 pathway |
Human, In vitro
|
Huh7, Sk-hep1, SMMC-7721, HepG2, L-02 |
(Zhu, Y. et al., 2019) |
Circ_0015756 |
Up |
miR-7 |
Human, In vitro
|
WRL-68, MHCC97H, Bel-7402, Huh-7, Bel100 |
(Liu et al., 2019b) |
hsa_circ_0085616 |
Up |
β-catenin, p-ERK,p-AKT, |
Human, In vitro
|
HepG2, MHCC-97L, MHCC-97H, Huh7, LM3 |
(Li et al., 2019) |
Hsa_circ_0003998 |
Up |
AFP, |
Human, In vitro
|
HepG-2, HuH7, MHCC97H, PLC/PRF/5, L02 |
(Qiao et al., 2019) |